Response to letter to the editor and comment concerning “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial”

This is a preview of subscription content, access via your institution.

Data availability

The datasets generated during and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. 1.

    Zhang D, Wu H, Kong Q (2021) Letter to the editor on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial.” Int Orthop 45(5):1365–1366

  2. 2.

    Dong H, Lu Y, Luo Y (2021) Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial". Int Orthop. https://doi.org/10.1007/s00264-021-05036-y

  3. 3.

    Zhang L, Li Y, Liu D et al (2020) Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. Int Orthop 44(10):2079–2087

    Article  Google Scholar 

  4. 4.

    Kvederas G, Porvaneckas N, Andrijauskas A et al (2013) A randomized double-blind clinical trial of tourniquet application strategies for total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 21(12):2790–2799

    Article  Google Scholar 

  5. 5.

    Sehat KR, Evans RL, Newman JH (2004) Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 86(4):561–5

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

All authors have approved the manuscript and agree with submission.

Corresponding author

Correspondence to Yunzhen Chen.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate

No consent for participation is required due to no personal data included.

Consent for publication

All authors have approved the manuscript and agree with submission to International Orthopaedics.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Li, Y., Liu, D. et al. Response to letter to the editor and comment concerning “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial”. International Orthopaedics (SICOT) (2021). https://doi.org/10.1007/s00264-021-05098-y

Download citation